Results of molecular studies have highlighted the presence of ARID1A gene mutations in 46% of clear-cell and 30% of endometrioid ovarian cancers and in areas of endometriosis that are contiguous with these cancers [8,9]. Here, ARID1A is linked to endometriosis.